openPR Logo
Press release

Metagenomics Market 2024 - Providing Industry Outlook, Evaluating Present Manufacturers, Analyzing Channels, and Offering a Comprehensive Forecast Till 2033

02-20-2024 10:37 AM CET | Health & Medicine

Press release from: The Business research company

Metagenomics Market

Metagenomics Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Metagenomics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The metagenomics market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes..

The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $3.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations.. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10815&type=smp

Market Segmentation:
The metagenomics market covered in this report is segmented -
1) By Product: Instruments, Kits And Reagents, Software And Services
2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis
3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes

Major Driver - The Impact Of Rising Infectious Disease Incidence On The Metagenomics Market
The rise in the incidence of infectious diseases is significantly contributing to the growth of the metagenomics market. Infectious diseases, also known as transmissible diseases, refer to illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, and can be transmitted from person to person or through other modes of transmission. Metagenomics is used to study infectious diseases by analyzing the genetic material of microbial communities. It allows for the comprehensive analysis of microbial communities associated with infectious agents, providing insights into their composition, genetic diversity, and potential interactions. For instance, in October 2022, according to an article published by the Pan American Health Organization, a US-based specialized agency of the United Nations, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021. Therefore, the increasing prevalence of infectious diseases is driving the growth of the metagenomics market.

Competitive Landscape:
Major companies operating in the metagenomics market report are Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Takara Bio USA Inc., BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Top Trend - The Impact Of Technological Advancements On The Metagenomics Market
Technological advancements are the key trend gaining popularity in the metagenomics market. Major companies operating in the metagenomics market are focused on adopting new genomics technologies to improve their observation power and sustain their position in the market. For instance, in May 2023, CD Genomics, a US-based genomics services company, launched the Long-Read Metagenomic Sequencing service. With its state-of-the-art technology, researchers and scientists are better equipped to understand the complexity of microbial communities with unmatched accuracy and depth. Clients can enter a new era of metagenomics research by utilizing CD Genomics' cutting-edge technology and genomic knowledge. Its key features include enhanced resolution, species identification, functional annotation, and comparative analysis. This advanced method is expected to transform metagenomics research by offering previously unattainable insights into microbial communities.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Metagenomics Market Characteristics
3. Metagenomics Market Trends And Strategies
4. Metagenomics Market - Macro Economic Scenario
5. Metagenomics Market Size And Growth
…..
27. Metagenomics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metagenomics Market 2024 - Providing Industry Outlook, Evaluating Present Manufacturers, Analyzing Channels, and Offering a Comprehensive Forecast Till 2033 here

News-ID: 3391059 • Views:

More Releases from The Business research company

Increasing Financial Fraud Incidents Propel Accounting and Auditing Market: A Key Catalyst Accelerating Accounting And Auditing Market Growth in 2025
Increasing Financial Fraud Incidents Propel Accounting and Auditing Market: A Ke …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Accounting And Auditing Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for accounting and auditing has seen a robust growth in the past few years. It is expected to increase from $222.35 billion in 2024 to $238.28 billion in 2025, reflecting a
Supply Chain Finance Market Expected to Achieve 8.6% CAGR by 2029: Growth Forecast Insights
Supply Chain Finance Market Expected to Achieve 8.6% CAGR by 2029: Growth Foreca …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Supply Chain Finance Market Size By 2025? The market size for supply chain finance has been experiencing a robust expansion in the past few years. The market, which is projected to escalate from $12.47 billion in 2024 to $13.42 billion in 2025, is expected to
Personal Loans Market on Track for Strong Growth, Estimated to Grow at 10.7% CAGR Through 2029
Personal Loans Market on Track for Strong Growth, Estimated to Grow at 10.7% CAG …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Personal Loans Market Through 2025? The personal loans industry has seen robust growth in recent years. The market size is projected to increase from $778.34 billion in 2024 to $854.94 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%.
Key Trends Reshaping the Mobile Wallet Market: Revolut Launches Innovative Mobile Wallet Feature to Enhance International Money Transfers Industry Transformation
Key Trends Reshaping the Mobile Wallet Market: Revolut Launches Innovative Mobil …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Mobile Wallet Market Size Growth Forecast: What to Expect by 2025? The scale of the mobile wallet market has experienced a monumental expansion in the past few years. Its morphology will evolve from $2109.19 billion in 2024 to a staggering $2754.87 billion by 2025, reflecting a compound annual growth

All 5 Releases


More Releases for Metagenomi

Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced. Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (N …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over
Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
In a world where healthcare innovation is accelerating, companies leveraging artificial intelligence are leading the charge in transforming patient care, diagnostics, and therapeutic solutions. Their advancements in smart disinfection, AI-designed therapies, precision gene editing, and cardiovascular diagnostics are not only reshaping their industries but also unlocking tremendous growth potential. Here's how these cutting-edge companies are redefining the future of healthcare. CS Diagnostics Corp. (OTCQB: CSDX) Launches Next-Gen Disinfectant MEDUSA a cutting-edge
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024. Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.
Investigation announced for Investors in shares of Metagenomi, Inc. (NASDAQ: MGX …
An investigation was announced for investors of Metagenomi, Inc. (NASDAQ: MGX) shares over potential securities laws violations by Metagenomi, Inc. Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Metagenomi, Inc. (NASDAQ: MGX) concerning whether a series